Xcout Intel
Outset Medical
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Subscribe to see Outset Medical’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Outset Medical at a glance
Outset Medical is a medical devices company headquartered in San Jose, United States. It is publicly listed (OM) with a market capitalisation of $75.1M. Xcout tracks 36 named people at Outset Medical, including Leslie L. Trigg (President, Chief Executive Officer & Chairman). Xcout recorded 118 job postings from Outset Medical in the last 90 days, naming tools such as Salesforce, Jira, Jenkins.
Outset Medical leadership
- Leslie L. TriggPresident, Chief Executive Officer & Chairman
- Leslie TriggChair and CEO
- Renee GaetaChief Financial Officer, Principal Financial Officer & Principal Accounting Officer
- Nabeel AhmedChief Financial Officer
- Brittni McGillChief Nursing Officer
- Michael AragonChief Medical Officer
30 more named people on record for Outset Medical, with roles, board committees and tenure — see the full roster →
Hiring at Outset Medical
Xcout recorded 118 job postings from Outset Medical in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Outset Medical's job postings
The weekly hiring trend, the roles and locations behind it — see Outset Medical's hiring signals →
Hiring vs the trend
Based on 46 job postings in the last 8 weeks (10 Aug – 4 Oct 2026), compared with 158 scale-up healthcare companies.
This describes a hiring pattern — how often Outset Medical’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Outset Medical competitors
A few of Outset Medical's closest competitors — see the full list of competitors and alternatives →
Quanta Dialysis Technologies is a medical-device company that develops hemodialysis systems, notably its compact SC+ platform. Its products are intended for use by dialysis providers and healthcare professionals in clinical and home-care settings to treat patients with kidney failure.
Venova Medical Inc. is a clinical-stage medical device company headquartered in Los Gatos, California. Founded in 2018, the firm focuses on addressing challenges associated with providing optimal vascular access for patients requiring hemodialysis. The privately held company develops specialized vascular technologies to improve patient care outcomes.
AWAK Technologies (now operating as Vivance) develops medical technology solutions for comprehensive kidney care, including ultraportable and wearable dialysis devices, point-of-care dialysis fluid generation, and digital AI integration for remote patient monitoring. The company serves patients with chronic kidney disease and end-stage renal disease by providing portable and personalized treatment options.
SWS Hemodialysis Care Co., Ltd., founded in 2001, is a medical enterprise in China specializing in the manufacture of blood purification equipment, including hemodialysis machines and continuous blood-purification devices. The company operates within the blood purification sector, producing products such as dialyzers.
Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems. Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products. Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers. The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.
Simergent, LLC develops the Archimedes automated peritoneal dialysis system, a home dialysis device designed to be affordable, easy to use, and accessible for patients with end-stage kidney disease. The device is FDA cleared for both clinic and home use, allowing patients to undergo treatment without requiring a caregiver.
Get Outset Medical's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Outset Medical in Xcout Intel
- 36 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access